@malcolm, Tutaj komentarz jednego z współautorów szczepionki
https://www.thenationalnews.com/world/europe/denmark-s-astrazeneca-vaccine-ban-could-lead-to-a-lot-of-dead-people-1.1204201

a tutaj jego słowa i coś o nim

Those tied to the vaccine have been at the center of promoting the idea that the COVID-19 vaccine will soon become an annual affair. For instance, in early May, John Bell—an Oxford medical professor and an “architect” of the Oxford-AstraZeneca partnership—told NBC News, “I suspect we may need to have relatively regular vaccinations against coronaviruses going into the future,” adding that the vaccine would likely be needed every year like the flu vaccine. NBC News failed to note that the Oxford-AstraZeneca vaccine in which Bell is involved stands to significantly benefit financially if that does come to pass.

More recently, Bell told The Week that, “should there prove to be a market for regular vaccinations against coronavirus in the future, ‘there is some money to be made.’” Such sentiments have been echoed by Pascal Soriot, the CEO of AstraZeneca, who told Bloomberg last month that the company stood to make a “reasonable profit” once the pandemic was declared over and COVID-19 deemed a seasonal illness requiring regular vaccinations. On this matter, Vaccitech’s CEO, Bill Enright, stated that Vaccitech investors would receive a “big chunk of the royalties from a successful vaccine as well as ‘milestone’ payments” if and when the pandemic is declared over and COVID-19 vaccines become a seasonal event.
https://web.archive.org/web/20201127212301/https://www.theweek.co.uk/107698/who-is-set-to-make-money-from-the-oxford-coronavirus-vaccine
https://news.sky.com/story/covid-19-the-multi-billion-pound-business-of-the-oxford-vaccine-12134833

kasa kasa kasa kasa yeah